Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma: multicenter study

Byun, JM; Park, SS; Yoon, SS; Ahn, A; Kim, M; Lee, JY; Jeon, YW; Shin, SH; Yahng, SA; Koh, Y; Min, CK

Koh, Y (通讯作者)，Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul, South Korea.;Min, CK (通讯作者)，Catholic Univ Korea, Seoul St Marys Hematol Hosp, Coll Med, Dept Hematol, 222 Banpo Daero, Seoul 06591, South Korea.

BLOOD RESEARCH, 2023; 58 (2): 83

Abstract

BackgroundThe goal of induction therapy for multiple myeloma (MM) is to achieve adequate disease control. Current guidelines favor triplet (bortezomib......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索